Vaccines: focus on adults - Summa Health System
Vaccines: focus on adults - Summa Health System
Vaccines: focus on adults - Summa Health System
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
MENINGOCOCCAL VACCINE• Vaccine characteristics• Inactive vaccine• Polysaccharide Quadrivalent-serogroupsA, C, Y, W-135• Quadrivalent C<strong>on</strong>jugate vaccine (Menactra)• Same serogroups; approved for ages 2-54• Better and L<strong>on</strong>ger immunity• Indicati<strong>on</strong>s(somewhat c<strong>on</strong>troversial)• College freshman(recommended by Am Coll of <strong>Health</strong>Assoc; not yet routinely recommended by CDC)• NOW Recommended by CDC with booster dose oftetravalent meningococcal vaccine should be routinelyadministered to adolescents 5 years after the first doseis given at ages 11 through 13 years (ACIP Oct 28,2010)• Travelers to high risk areas
Change language